A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
贝伐珠单抗和卢卡帕尼治疗复发性宫颈癌或子宫内膜癌的II期临床试验
期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2022.04.016
Jackson, C G; Moore, K N; Cantrell, L; Erickson, B K; Duska, L R; Richardson, D L; Landrum, L M; Holman, L L; Walker, J L; Mannel, R S; Moxley, K M; Queimado, L; Cohoon, A; Ding, K; Dockery, L E